Education
About Us
Working with TipRanks
Follow Us
Ventas Inc (DE:VEN)
:VEN
VEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range€46.34 - €66.76
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€73.60B
Enterprise Value€29.61B
Total Cash (Recent Filing)€182.34M
Total Debt (Recent Filing)$12.92B
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Jul 31, 2025EPS Estimate
0.12Next Dividend Ex-Date
Jun 30, 2025Dividend Yield3.01%
Share Statistics
EPS (TTM)0.09
Shares Outstanding451,376,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.23
Price to Book (P/B)1.66
Price to Sales (P/S)0.00
P/FCF Ratio25.25
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue1.52
Enterprise Value/Gross Profit15.89
Enterprise Value/Ebitda3.93
Forecast
1Y Price Target
€63.72Price Target Upside17.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Ventas News
PremiumCompany Announcements
Ventas Amends ATM Sales Agreement to $2.25 Billion
PremiumCompany Announcements
Ventas Realty Issues $500 Million in Senior Notes
PremiumCompany Announcements
Ventas Approves Key Amendments at Annual Meeting
PremiumCompany Announcements
Ventas Inc: Strong Q1 2025 Performance in Senior HousingBulls Say, Bears Say
Bulls Say
AcquisitionsVTR has increased its 2024 acquisition guidance significantly, taking advantage of its declining cost of equity.
Dividend IncreaseVentas Inc's Board of Directors declared a quarterly dividend of $0.48 per share, representing a 7% increase.
Financial PerformanceVentas Inc improved its 2025 outlook for Normalized FFO per share to $3.41, which is a 7% increase year-over-year, led by SHOP.
Bears Say
GuidanceShares may initially react negatively given the beat and improved acquisitions without a guidance bump.
Occupancy RatesOccupancy is below expectations due to elevated mortality rates.
Research And DevelopmentResearch is also a risk given lab/NIH pressures.
Options Prices
Currently, No data available
---
Ownership Overview
0.46% Insiders
27.92%
Mutual Funds
16.12% Other Institutional Investors
26.01% Public Companies and Individual Investors
VEN FAQ
What was Ventas Inc’s price range in the past 12 months?
Ventas Inc lowest stock price was €46.34 and its highest was €66.76 in the past 12 months.
What is Ventas Inc’s market cap?
Ventas Inc’s market cap is €73.60B.
When is Ventas Inc’s upcoming earnings report date?
Ventas Inc’s upcoming earnings report date is Jul 31, 2025 which is in 43 days.
How were Ventas Inc’s earnings last quarter?
Ventas Inc released its earnings results on Apr 30, 2025. The company reported €0.088 earnings per share for the quarter, beating the consensus estimate of €0.084 by €0.004.
Is Ventas Inc overvalued?
According to Wall Street analysts Ventas Inc’s price is currently Undervalued.
Does Ventas Inc pay dividends?
Ventas Inc pays a Quarterly dividend of €1.58 which represents an annual dividend yield of 3.01%. See more information on Ventas Inc dividends here
What is Ventas Inc’s EPS estimate?
Ventas Inc’s EPS estimate is 0.12.
How many shares outstanding does Ventas Inc have?
Ventas Inc has 451,376,300 shares outstanding.
What happened to Ventas Inc’s price movement after its last earnings report?
Ventas Inc reported an EPS of €0.088 in its last earnings report, beating expectations of €0.084. Following the earnings report the stock price went down -4.737%.
Which hedge fund is a major shareholder of Ventas Inc?
Currently, no hedge funds are holding shares in DE:VEN
Ventas Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€63.72 (17.31% Upside)
€63.72 (17.31% Upside)
Blogger Sentiment
Bullish
DE:VEN Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.28%
12-Months-Change
Fundamentals
Return on Equity
1.36%
Trailing 12-Months
Asset Growth
5.51%
Trailing 12-Months
Company Description
Ventas Inc
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
VEN Company Deck
VEN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights Ventas's strong first-quarter performance, driven by significant growth in their senior housing segment and increased investment activities. While the company faces some challenges, such as seasonal move-outs and research segment performance, the overall outlook remains positive due to favorable demographic trends and strategic portfolio management.Read More>VEN Revenue Breakdown
68.49% SHOP
17.82% OM&R
12.63% NNN
1.05% Non-Segment
VEN Stock 12 Month Forecast
Average Price Target
€63.72
▲(17.31%Upside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Healthcare Realty Trust
―
CareTrust REIT
―